These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

119 related items for PubMed ID: 6432023

  • 1. How many plasma theophylline levels are needed to control therapy?
    Ullah MI.
    Br J Clin Pract Suppl; 1984; 32():32. PubMed ID: 6432023
    [No Abstract] [Full Text] [Related]

  • 2. Clinical results obtained from a new controlled release theophylline preparation.
    Nolte D.
    Br J Clin Pract Suppl; 1984; 32():14-7. PubMed ID: 6432017
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. [Theophyllin-dosage in adults; blood level determination as therapeutic control].
    Lunde PK, Lange-Nielsen F, Brørs O.
    Tidsskr Nor Laegeforen; 1980 Jan 30; 100(3):173-74. PubMed ID: 7385143
    [No Abstract] [Full Text] [Related]

  • 5. [Microcrystallinic theophylline, plasma concentration and adverse effects in patients with obstructive lung disease].
    Talseth T, Kongerud J, Boye NP, Bredesen JE.
    Tidsskr Nor Laegeforen; 1981 Oct 20; 101(29):1648-50. PubMed ID: 7339948
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. [Clinical study of theophyllinemia in patients with obstructive bronchial syndrome].
    Vasiliev CB, Burnea D, Vasiliev R, Popescu C, Anastasatu C.
    Rev Ig Bacteriol Virusol Parazitol Epidemiol Pneumoftiziol Pneumoftiziol; 1983 Oct 20; 32(2):169-80. PubMed ID: 6316471
    [No Abstract] [Full Text] [Related]

  • 8. Experiences with various preparations of ephedrine theophylline combination in chronic obstructive pulmonary disease.
    Kamat SR, Panandikar SG, Purohit SD, Jagasia RS, Kulkarni ST.
    Indian J Chest Dis Allied Sci; 1976 Jan 20; 18(1):25-35. PubMed ID: 1270089
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. [Optimizing therapy with theophylline preparations in obstructive ventilation disorders. 3. Prediction of theophylline clearance with a simple pharmacokinetic method and comparison of bioavailability of various theophylline retard preparations].
    Ranke C, Schmidt G, Oellerich M, Sybrecht GW.
    Prax Klin Pneumol; 1983 Mar 20; 37(3):99-108. PubMed ID: 6856564
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. [Individual theophylline doses following ambulatory determination of theophylline clearance].
    Harder S, Staib AH, Stauder J.
    Prax Klin Pneumol; 1986 Aug 20; 40(8):334-8. PubMed ID: 3748986
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.